The XAPIEN team represents many years of experience in the Life Science Informatics, Proteomics and Drug Discovery industries. Several members were closely involved in one of the largest ever Life Science Informatics deals (valued at approximately $100million) while concurrently guiding that company through a dual listing on Germany's "Neuer Markt" and the American NASDAQ stock markets.
Our joint efforts have also resulted in more than 25 patents (applications and granted) and more than 100 publications in top scientific journals including Nature, Cell, and Science. This experience has collectively resulted in an extensive network of key scientific and business contacts. We intend to build on this foundation by attracting proven and complementary business and management strength.